Showing posts with label Major. Show all posts
Showing posts with label Major. Show all posts

Tuesday, March 29, 2011

Major EU Project To Study The Health Of Migrants From North Africa


Main Category: Public Health
Article Date: 21 Mar 2011 - 1:00 PDT window.fbAsyncInit = function() { FB.init({ appId: 'aa16a4bf93f23f07eb33109d5f1134d3', status: true, cookie: true, xfbml: true, channelUrl: 'http://www.medicalnewstoday.com/scripts/facebooklike.html'}); }; (function() { var e = document.createElement('script'); e.async = true; e.src = document.location.protocol + '//connect.facebook.net/en_US/all.js'; document.getElementById('fb-root').appendChild(e); }()); email icon email to a friend   printer icon printer friendly   write icon opinions
not yet ratednot yet rated
The Centre for Primary Health Care Research aims to improve the conditions for immigrants to the EU through research and by providing recommendations for health policy measures. The CPF will coordinate the Swedish contribution to a major EU project that has received EUR 2 million to study the health of migrants from North Africa.

"We are pleased to have been entrusted with the coordination of the Swedish contribution to such a complex, exciting and important EU project, which puts the health and quality of life of North African migrants in focus", says Jan Sundquist, Director of the Centre for Primary Health Care Research (CPF), a research centre operated jointly by Lund University and Region Skåne.

Human health is complex, even in a single population. For migrants, whose life situation is always influenced by both their host country and their country of origin, the picture is even more complicated.

"It is therefore important to map health, diseases and use of health care services for immigrants and to compare the data with that for the native population. However, such analyses would be incomplete if the same parameters were not also studied in the country of origin", says Jan Sundquist.

The project, which is called EU and North African Migrants: Health and Health Systems (EUNAM), has assembled a team of experts from Egypt, Tunisia, Algeria, France, Italy, Germany, Slovenia and Sweden, whose combined experience covers all health aspects of the migration cycle. The group will look at the health situation both in the North African partner countries of Egypt, Tunisia and Algeria, from which a large number of immigrants to the EU come, and for migrants living in Europe.

France, Italy, Germany, Slovenia and Sweden are not only recipients of North African migrants, but also have a large number of immigrants from other regions. This allows comparisons to be made between different migrant groups.

"Collectively, the group of experts has a lot of experience of disease prevention work and has access to material and registers containing information on population health and disease patterns and the effects these have on the health care system", says Jan Sundquist.

A lot of the data that will be used in the study has already been compiled by the participating countries. The participants will have access to these unique sources of data.

"We have a good starting point from which to be able to deliver research-based evaluations and recommendations for scientific and health policy measures that will improve conditions for immigrants to the EU", concludes Jan Sundquist.

Source:
Jan Sundquist
Lund University

Bookmark and Share

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:



MediLexicon International Ltd Logo
Privacy Policy | Terms and Conditions

MediLexicon International Ltd
Bexhill-on-Sea, UK
MediLexicon International Ltd © 2004-2011 All rights reserved.



View the original article here

Thursday, March 24, 2011

New Technology Promises To Have A Major Impact On Supply Of Malaria Treatment Across The Developing World


Main Category: Tropical Diseases
Also Included In: Women's Health / Gynecology;  Pediatrics / Children's Health
Article Date: 21 Mar 2011 - 1:00 PDT window.fbAsyncInit = function() { FB.init({ appId: 'aa16a4bf93f23f07eb33109d5f1134d3', status: true, cookie: true, xfbml: true, channelUrl: 'http://www.medicalnewstoday.com/scripts/facebooklike.html'}); }; (function() { var e = document.createElement('script'); e.async = true; e.src = document.location.protocol + '//connect.facebook.net/en_US/all.js'; document.getElementById('fb-root').appendChild(e); }()); email icon email to a friend   printer icon printer friendly   write icon opinions
not yet ratednot yet rated
Canada is delivering on its commitment to help the world's most vulnerable, thanks to new developments which will provide an affordable, reliable, and stable treatment for malaria that will save millions of lives, especially those of women and children in Africa. The Honourable Gary Goodyear, Minister of State for Science and Technology, along with Mr. Brad Trost, Member of Parliament for Saskatoon-Humboldt, announced the breakthrough and highlighted the Government's research support.

"Our government is committed to improving the health of women and children in developing countries," said Minister Goodyear. "This new development in the production of a malaria treatment represents a major development in the fight against the disease. It will strengthen Canada's position as a world leader in health research and provide a reliable and affordable solution."

This announcement is a result of The Artemisinin Project, a public-private partnership led by OneWorld Health in collaboration with sanofi-aventis, Amyris, the University of California at Berkeley, and the National Research Council of Canada. Artemisinin is a natural compound found in a traditional Chinese medicinal plant grown mainly in Africa and Asia to treat malaria. The Government of Canada's investment of approximately $869,000 in this research has led to technology that can produce a stable and affordable supply of artemisinin for the developing world on a not-for-profit basis.

"Collaboration on the development of this new technology promises to have a major impact on supply of malaria treatment across the developing world, which will be an important contribution towards the global effort to combat malaria," said Dr. Richard Chin, Chief Executive Officer of OneWorld Health.

According to the World Health Organization, malaria causes approximately 250 million illnesses and more than one million deaths each year, of which 90 percent occur in Africa, mostly in pregnant women and in children. The disease is endemic in nearly 100 countries, including 28 on the African continent. This project is expected to help treat 200 million cases and prevent over one million deaths annually.

Source:
Media Relations
National Research Council of Canada

Bookmark and Share

Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.

Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.

If you write about specific medications or operations, please do not name health care professionals by name.

All opinions are moderated before being included (to stop spam)

Contact Our News Editors

For any corrections of factual information, or to contact the editors please use our feedback form.

Please send any medical news or health news press releases to:



MediLexicon International Ltd Logo
Privacy Policy | Terms and Conditions

MediLexicon International Ltd
Bexhill-on-Sea, UK
MediLexicon International Ltd © 2004-2011 All rights reserved.



View the original article here